Related Experiment Video
Updated: Jul 18, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Paradoxical response to tacrolimus assessed by interleukin-2 gene expression
E A El-Safa1, S Fredericks, I MacPhee
1Department of Clinical Pharmacology, William Harvey Research Institute, Barts and The London, London, United Kingdom. E.A.EL-SAFA@QMUL.AC.UK
Transplantation Proceedings
|December 19, 2006
Summary
Measuring interleukin-2 (IL-2) mRNA expression can assess calcineurin inhibitor drug efficacy. This method shows potential for monitoring immunosuppressive therapy in transplant patients.
Area of Science:
- Immunology
- Pharmacology
- Molecular Biology
Background:
- Calcineurin inhibitors like cyclosporine and tacrolimus are crucial immunosuppressants post-organ transplantation.
- Effective monitoring of calcineurin inhibitor pharmacodynamics remains a clinical challenge.
Purpose of the Study:
- To evaluate quantitative interleukin-2 (IL-2) mRNA expression as a pharmacodynamic marker for calcineurin inhibitors.
- To assess the feasibility of using IL-2 mRNA levels to monitor immunosuppressive drug efficacy.
Main Methods:
- Whole blood samples from healthy volunteers and renal transplant patients were incubated with tacrolimus.
- Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) was used to measure IL-2 mRNA expression.
- IL-2 mRNA copy number was quantified using TaqMan probes and a standard curve.
Main Results:
- Tacrolimus generally suppressed IL-2 mRNA synthesis in healthy volunteers, but some samples showed upregulation.
- Two patient samples exhibited IL-2 mRNA upregulation, and these patients later developed acute rejection post-transplantation.
- A correlation between IL-2 mRNA expression patterns and clinical outcomes was observed in transplant patients.
Conclusions:
- Quantitative IL-2 mRNA expression analysis offers a potential method for assessing calcineurin inhibitor efficacy.
- This gene expression assay may serve as a valuable tool for monitoring immunosuppressive therapy in organ transplant recipients.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...